A7817 — Relates to pharmacy benefits where a physician is authorized to dispense certain medications and practices medicine in the oncology setting
Last action — In Assembly Committee
-
1Introduced
-
2In Committee
-
3Passed Assembly
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill has been introduced in the Assembly. Introduced April 11, 2025. It must pass committee before a floor vote.
Next likely step: a committee referral and hearing.
Prognosis
Where this bill stands today.
Odds of enactment
LowHow often bills like it became law.
Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.
Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.
Summary
Relates to excepting situations where a physician or other licensed health care provider is authorized to dispense certain medications and is practicing medicine in the oncology setting and is dispensing oncology drugs or drugs related to an approved course of treatment used to manage symptoms related to cancer or cancer therapies.
Bill Text
- Full text View text Current
Action History
-
PRINT NUMBER 7817A
-
AMEND AND RECOMMIT TO HEALTH
-
REFERRED TO HEALTH
-
REFERRED TO HEALTH
Sponsors
- Amy Paulin · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 218 not signed on
Sponsors (1)
Co-sponsors (0)
None.
Not signed on (218)
218 members have not signed on to this bill.
Show all 218 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does A7817 do?
- Relates to excepting situations where a physician or other licensed health care provider is authorized to dispense certain medications and is practicing medicine in the oncology setting and is dispensing oncology drugs or drugs related to an approved course of treatment used to manage symptoms related to cancer or cancer therapies.
- Who sponsors A7817?
- A7817 is sponsored by Amy Paulin.
- What is the current status of A7817?
- This bill has been introduced in the Assembly. Introduced April 11, 2025. It must pass committee before a floor vote.
- Where can I track A7817?
- Track A7817 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on A7817
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of A7817
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →